Skip to main content
OpenTrials

Clinical trial condition

Esophageal Diseases

Explore clinical trials studying Esophageal Diseases. Study availability and eligibility vary by location and protocol.

3,519 public trials 713 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Diseases trial results

Recruiting

Integrated Cancer Repository for Cancer Research

NCT02012699

Conditions
Abdominal Neoplasms, Adenoma, Adenomatous Polyposis Coli, +195 more
Locations
  • Advent Health Greenwood Village, Colorado, United States
  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital Manchester, Connecticut, United States
  • Florida Hospital Memorial Medical Center Daytona Beach, Florida, United States
  • Florida Hospital DeLand DeLand, Florida, United States
View all 42 locations
View Trial Details
Recruiting

EMR Versus ESD for Barrett's Neoplasia

NCT05276791

Conditions
Barrett Adenocarcinoma, Barrett Esophagus, Barretts Esophagus With Dysplasia, +11 more
Locations
  • Amsterdam University Medical Center Amsterdam, Netherlands
  • Catharina Ziekenhuis Eindhoven, Netherlands
  • University Medical Center Groningen Groningen, Netherlands
  • St. Antonius Ziekenhuis Nieuwegein, Netherlands
View Trial Details
Recruiting

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

NCT06747585

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cervical Squamous Cell Carcinoma, +16 more
Locations
  • Mayo Foundation for Medical Education and Research - Mayo Cl Scottsdale, Arizona, United States
  • Providence Medical Foundation Fullerton, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
View all 41 locations
View Trial Details
Recruiting

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

NCT05319730

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 4927) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 4905) Los Angeles, California, United States
  • Hematology-Oncology Associates of Central NY, P.C. ( Site 4925) East Syracuse, New York, United States
  • Columbia University Irving Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical ( Site 4907) New York, United States
View all 59 locations
View Trial Details
Recruiting

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

NCT05005403

Conditions
Anophthalmia with pulmonary hypoplasia, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • City of Hope National Medical Center /ID# 276272 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589 Irvine, California, United States
  • USC Norris Comprehensive Cancer Center /ID# 279603 Los Angeles, California, United States
  • University of Illinois Hospital and Health Sciences System /ID# 251750 Chicago, Illinois, United States
View all 48 locations
View Trial Details
Recruiting

Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disease (GERD) Symptoms

NCT06613438

Conditions
Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations
  • Division of Gastroenterology & Hepatology Feinberg School of Medicine Northwestern University Chicago, Illinois, United States
  • Gastroenterology department, Emek medical center (EMC) Afula, Israel
  • Gastroenterology department, Rambam Health Care Campus Haifa, Israel
  • Gastroenterology department, Rabin medical center (RMC) Petah Tikva, Israel
View Trial Details

Related conditions